Rheumatoid Arthritis Clinical Trials in Los Angeles

Showing 2021-2040 of 2,731 trials

Poly-ICLC in Treating Patients With Recurrent or Progressive Anaplastic Glioma

NCT00058123

RATIONALE: Biological therapies such as poly-ICLC use different ways to stimulate the immune system and stop tumor cells from growing. PURPOSE: This phase II trial is studying how poly-ICLC works in treating patients with recurrent, progressive, or relapsed anaplastic glioma.

Brain and Central Nervous System Tumors

Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins55 participantsStarted Mar 2003

Los Angeles, California, United States • San Francisco, California, United States • Boston, Massachusetts, United States +5 more locations

TERMINATEDPhase 1< 1 mile

Dabrafenib in Treating Patients With Solid Tumors and Kidney or Liver Dysfunction

NCT01907802

This phase I trial studies the side effects and best dose of dabrafenib in treating patients with solid tumors and kidney or liver dysfunction. Dabrafenib may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth.

BRAF Gene MutationHepatic ComplicationRenal Failure+1 more

National Cancer Institute (NCI)8 participantsStarted Aug 2013

Duarte, California, United States • Los Angeles, California, United States • Sacramento, California, United States +15 more locations

Poly-ICLC in Treating Patients With Recurrent or Progressive Anaplastic Glioma

Dabrafenib in Treating Patients With Solid Tumors and Kidney or Liver Dysfunction

Rheumatoid Arthritis Trials in Other Cities

Presatovir in Hematopoietic Cell Transplant Recipients With Respiratory Syncytial Virus Infection of the Upper Respiratory Tract

Assessing the Use of Certolizumab Pegol in Adult Subjects With Rheumatoid Arthritis on the Antibody Response When Receiving Influenza Virus and Pneumococcal Vaccines

Certolizumab Pegol for the Treatment of Patients With Active Rheumatoid Arthritis

Study to Assess the Short- and Long-term Efficacy of Certolizumab Pegol Plus Methotrexate Compared to Adalimumab Plus Methotrexate in Subjects With Moderate to Severe Rheumatoid Arthritis (RA) Inadequately Responding to Methotrexate

A Comparison of Two Assessment Tools in Predicting Treatment Success of Cimzia in Rheumatoid Arthritis Subjects

An Observational Study of The Safety of MabThera/Rituxan (Rituximab) in Participants With Granulomatosis With Polyangiitis (Wegener's) or Microscopic Polyangiitis

Imetelstat Sodium in Treating Younger Patients With Recurrent or Refractory Brain Tumors

Safety and Effectiveness of the Calhoun Vision Light Adjustable Intraocular Lens (LAL)

Safety & Efficacy of Corneal Collagen Cross-Linking in Eyes With Keratoconus or Corneal Ectasia After Refractive Surgery

Clazosentan in Aneurysmal Subarachnoid Hemorrhage

Pilot Study of X-82 in Patients With Wet AMD

The Use of cineMRI to Evaluate Botox in Patients With Medication Refractory Overactive Bladder

Rapid Amniotic Fluid (AF) Test and a Non-Invasive Vaginal Fluid (VF) Test

Long-Term Effects of Treatment in Patients Previously Treated for Childhood Hodgkin's Lymphoma

Transfusion Requirements in Cardiac Surgery III

Safety/Pharmacokinetic Study Comparing Intracisternal EG-1962 to Standard of Care Enteral Nimodipine in Adults With aSAH

Everolimus (RAD001) for Children With Chemotherapy-Refractory Progressive or Recurrent Low-Grade Gliomas

A Two-Arm Study Evaluation H.P. Acthar Injection Gel in Treatment of Chronic Migraines

Other Conditions in Los Angeles